NW PharmaTech is a pharmaceutical company with a ‘Nature to Medicine’ strategy, utilising the latest technological developments in the pharmaceutical industry to bring to market a new generation of medicinal products based on natural compounds with promising therapeutic properties. Our aim is to provide people with natural solutions relevant to their everyday challenges.
Our R&D work revolves around known natural compounds with promising therapeutic properties. While utilising a proprietary micelle technology platform for superior bioavailability, we have partnered with a leading AI proteomic platform to analyse the pharmacological footprint of each compound.
We are working towards offering market leading Active Pharmaceutical Ingredients with superior bioavailability - which we utilize in-house for our clinical work in bringing to market proprietary medicines - to pharmaceutical clients, for development under indications outside of our primary scope of interest.
Our mission is to develop a new generation of medicines based on known natural compounds with promising therapeutic properties. Given the unique characteristics of cannabidiol (CBD) - both in terms of its biochemical properties and potential therapeutic effects – it is the first molecule we are working on and we are aiming to advance it to a licensed medicine for the indications of anxiety and sleep.
We are a driven team of specialists, committed to advancing the naturally derived medicine industry. Our team has experience across multiple sectors – pharmaceutical operations, research and development, intellectual property, marketing and finance – and is based in the UK, Europe and North America.